Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gross

Showing results (851-860 of 976) with videos related to

Pageof 98
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|October 22, 2009
Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patientsVikram D Kekatpure, Jay O Boyle, Xi Kathy Zhou, et al.
Journal of the American Heart Association|September 16, 2015
High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of AtherosclerosisDaniel A Duprez, James Otvos, Russell P Tracy, et al.
JAMA Otolaryngology-- Head & Neck Surgery|December 21, 2023
Comparison of da Vinci Single Port vs Si Systems for Transoral Robotic-Assisted Surgery: A Review With Technical InsightsNicholas Oberhelman, Jennifer Bruening, Ryan S Jackson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Radioimmunoscintigraphy of human met-expressing tumor xenografts using met3, a new monoclonal antibodyRick V Hay, Brian Cao, R Scot Skinner, et al.
Journal of Medicinal Chemistry|May 16, 2003
Identification of 1-arylmethyl-3- (2-aminoethyl)-5-aryluracil as novel gonadotropin-releasing hormone receptor antagonistsYun-Fei Zhu, Timothy D Gross, Zhiqiang Guo, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Uracils as potent antagonists of the human gonadotropin-releasing hormone receptor without atropisomersZhiqiang Guo, Yongsheng Chen, Charles Q Huang, et al.
Oral Oncology|March 31, 2019
Patient-reported outcomes of symptom burden in patients receiving surgical or nonsurgical treatment for low-intermediate risk oropharyngeal squamous cell carcinoma: A comparative analysis of a prospective registryMoran Amit, Kate Hutcheson, Jhankruti Zaveri, et al.
Advances in Therapy|January 1, 2008
Perception and quality of life associated with the use of olopatadine 0.2% (Pataday) in patients with active allergic conjunctivitisStephen V Scoper, Gregg J Berdy, Steven J Lichtenstein, et al.
Cancer Medicine|October 14, 2022
Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicityMehdi Hemmati, Carly Barbon, Abdallah S R Mohamed, et al.
Plos One|May 13, 2021
Identification of recombinant Fabs for structural and functional characterization of HIV-host factor complexesNatalia Sevillano, Evan M Green, Jörg Votteler, et al.
Pageof 98

Showing results (851-860 of 976) with videos related to

Sort By:
Pageof 98
Cancer Prevention Research (Philadelphia, Pa.)|October 22, 2009
Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patientsVikram D Kekatpure, Jay O Boyle, Xi Kathy Zhou, et al.
Journal of the American Heart Association|September 16, 2015
High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of AtherosclerosisDaniel A Duprez, James Otvos, Russell P Tracy, et al.
JAMA Otolaryngology-- Head & Neck Surgery|December 21, 2023
Comparison of da Vinci Single Port vs Si Systems for Transoral Robotic-Assisted Surgery: A Review With Technical InsightsNicholas Oberhelman, Jennifer Bruening, Ryan S Jackson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Radioimmunoscintigraphy of human met-expressing tumor xenografts using met3, a new monoclonal antibodyRick V Hay, Brian Cao, R Scot Skinner, et al.
Journal of Medicinal Chemistry|May 16, 2003
Identification of 1-arylmethyl-3- (2-aminoethyl)-5-aryluracil as novel gonadotropin-releasing hormone receptor antagonistsYun-Fei Zhu, Timothy D Gross, Zhiqiang Guo, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Uracils as potent antagonists of the human gonadotropin-releasing hormone receptor without atropisomersZhiqiang Guo, Yongsheng Chen, Charles Q Huang, et al.
Oral Oncology|March 31, 2019
Patient-reported outcomes of symptom burden in patients receiving surgical or nonsurgical treatment for low-intermediate risk oropharyngeal squamous cell carcinoma: A comparative analysis of a prospective registryMoran Amit, Kate Hutcheson, Jhankruti Zaveri, et al.
Advances in Therapy|January 1, 2008
Perception and quality of life associated with the use of olopatadine 0.2% (Pataday) in patients with active allergic conjunctivitisStephen V Scoper, Gregg J Berdy, Steven J Lichtenstein, et al.
Cancer Medicine|October 14, 2022
Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicityMehdi Hemmati, Carly Barbon, Abdallah S R Mohamed, et al.
Plos One|May 13, 2021
Identification of recombinant Fabs for structural and functional characterization of HIV-host factor complexesNatalia Sevillano, Evan M Green, Jörg Votteler, et al.
Pageof 98